Assessment of current practice for β-lactam therapeutic drug monitoring in French ICUs in 2021: a nationwide cross-sectional survey.

Perrine TritscherMatthieu DelannoyNelly AgrinierAlexandre CharmillonNicolas DegandJean DellamonicaClaire RogerMarc LeoneJulien Scala-Bertola Emmanuel Novy

Published in: The Journal of antimicrobial chemotherapy (2022)

Despite the publication of international guidelines, β-lactam TDM is not optimally used in French ICUs. The two major barriers are β-lactam TDM interpretation and the required time for results.

Keyphrases

gram negative
healthcare
primary care
multidrug resistant
cross sectional